HHGC
CERE

Hunting Hill Global Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Hunting Hill Global Capital’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,926
Closed -$242K – 112
2024
Q2 		$242K Sell
5,926
-953
-14% -$39.7K 0.11% 81
2024
Q1 		$291K Buy
+6,879
New +$289K 0.14% 86

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Hunting Hill Global Capital's CERE Position: Q3 2024 in Review

Hunting Hill Global Capital sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 5,926 shares — an estimated $242K sold.

Hunting Hill Global Capital first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $291K in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Hunting Hill Global Capital reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Hunting Hill Global Capital sold 5,926 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $242K.
  • Hunting Hill Global Capital first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Hunting Hill Global Capital's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $291K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Hunting Hill Global Capital's 13F filing for Q3 2024, filed 14 Nov 2024.